Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 15,084 | 22,464 | 18,704 | 17,703 | 15,848 |
| Operating Income | -15,084 | -22,464 | -18,704 | -17,703 | -15,848 |
| Other Income | 697 | 876 | 1,106 | 1,387 | 1,481 |
| Pre-tax Income | -14,387 | -21,588 | -17,598 | -16,316 | -14,367 |
| Net Income Continuous | -14,387 | -21,588 | -17,598 | -16,316 | -14,367 |
| Net Income | $-14,387 | $-21,588 | $-17,598 | $-16,316 | $-14,367 |
| EPS Basic Total Ops | -0.66 | -0.99 | -0.81 | -0.75 | -0.66 |
| EPS Basic Continuous Ops | -0.66 | -0.99 | -0.82 | -0.75 | -0.66 |
| EPS Diluted Total Ops | -0.66 | -0.99 | -0.81 | -0.75 | -0.66 |
| EPS Diluted Continuous Ops | -0.66 | -0.99 | -0.82 | -0.75 | -0.66 |
| EPS Diluted Before Non-Recurring Items | -0.66 | -0.99 | -0.81 | -0.75 | -0.66 |
| EBITDA(a) | $-15,092 | $-22,571 | $-18,927 | $-18,065 | $-16,457 |